The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Nanoliposomal irinotecan-based chemotherapy after regular irinotecan-based chemotherapy in patients with pancreas cancer.
 
Caleb J Smith
No Relationships to Disclose
 
Tanios S. Bekaii-Saab
Consulting or Advisory Role - Abbvie; Amgen (Inst); Bayer (Inst); Celgene (Inst); Immuneering; Imugene; Incyte (Inst); Ipsen (Inst); Lilly (Inst); Pfizer (Inst); Roche/Genentech (Inst); Seagen (Inst)
Other Relationship - ARMO BioSciences; AstraZeneca; Exelixis; Lilly; Merck (Inst); Sillajen
 
Kathryn Cook
No Relationships to Disclose
 
Rachel Eiring
No Relationships to Disclose
 
Thorvardur Ragnar Halfdanarson
Consulting or Advisory Role - Advanced Accelerator Applications (Inst); Curium Pharma; Ipsen (Inst); Lexicon (Inst); ScioScientific; TERUMO
Research Funding - Agios (Inst); ArQule (Inst); Basilea (Inst); Ipsen (Inst); Thermo Fisher Scientific (Inst)
 
Mina Samir Erian Hanna
No Relationships to Disclose
 
Zhaohui Jin
No Relationships to Disclose
 
Jacob A. Jochum
No Relationships to Disclose
 
Wen Wee Ma
Research Funding - Actuate Therapeutics (Inst); Athenex (Inst); Bristol-Myers Squibb (Inst); Ipsen (Inst); Merrimack (Inst); Sun Pharma (Inst)
 
Jessica L Mitchell
No Relationships to Disclose
 
Henry C. Pitot
No Relationships to Disclose
 
Aminah Jatoi
Research Funding - AstraZeneca (Inst)